Doug Swan is the VP, Commercial Operations at Biodesix.Mr. Swan has served in sales and marketing positions for over 25 years at companies including Bristol- Myers Squibb, Baxter Healthcare, Genentech Inc., and ImClone Systems. In his most recent position at ImClone, Mr. Swan served as Vice President, Field Operations, and was responsible for sales and reimbursement. Prior to joining ImClone, Mr. Swan was responsible for North America Sales and Marketing at Baxter Healthcare in Deerfield, IL. From 1996 to 1999, Mr. Swan served as the Director of Marketing at Genentech Inc., where he was responsible for the launch of monoclonal antibody therapies targeting non-Hodgkin’s lymphoma and breast cancer.